(C) is incorrect because even though researchers rely on funding that is in part contingent on patentability of their work, their personal views regarding biotechnology patents have no bearing on their funding or ability to patent their work for that matter.
(D) is correct because lines 23-27 discuss other options available to the patent holder aside from litigation, such as a materials-transfer agreement or a license agreement.
